Literature DB >> 1373724

Studies on the structure and binding properties of the cysteine-rich domain of rat low affinity nerve growth factor receptor (p75NGFR).

A N Baldwin1, C M Bitler, A A Welcher, E M Shooter.   

Abstract

The binding domain of p75NGFR contains four "repeats" of a 6-cysteine pattern. To test whether these repeats have any structural or functional independence, each repeat has been separately deleted. In each case, deletion led to the loss of most nerve growth factor (NGF) binding activity. The epitopes of two monoclonal antibodies, MC192 and 271c, could be distinguished, however. Repeat IV was found to be unnecessary for binding MC192, whereas Repeat I was not required for binding 217c. This suggests that either terminal repeat can be removed without loss of native-like structure in the remaining repeats. Trp155 in the fourth repeat forms an essential part of the 217c epitope but is not required for either MC192 or NGF binding. Deletion of the linker region between the membrane-spanning domain and the cysteine-rich domain does not affect the binding of NGF or MC192, and has only a slight, if any, effect on 217c binding. Cyclic permutation of the four repeats failed to yield protein capable of binding NGF or MC192.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

2.  Neurotrophin dependence domain: a domain required for the mediation of apoptosis by the p75 neurotrophin receptor.

Authors:  S Rabizadeh; X Ye; S Sperandio; J J Wang; H M Ellerby; L M Ellerby; C Giza; R L Andrusiak; H Frankowski; Y Yaron; N N Moayeri; G Rovelli; C J Evans; L L Butcher; G P Nolan; N Assa-Munt; D E Bredesen
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

3.  Construction of a mutated pro-nerve growth factor resistant to degradation and suitable for biophysical and cellular utilization.

Authors:  Promila C Pagadala; Laura A Dvorak; Kenneth E Neet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

4.  Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells.

Authors:  G Rovelli; R A Heller; M Canossa; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

5.  Modeled structure of the 75-kDa neurotrophin receptor.

Authors:  B S Chapman; I D Kuntz
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

6.  Circular dichroism and crosslinking studies of the interaction between four neurotrophins and the extracellular domain of the low-affinity neurotrophin receptor.

Authors:  D E Timm; A H Ross; K E Neet
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

7.  A novel p75 neurotrophin receptor-related protein, NRH2, regulates nerve growth factor binding to the TrkA receptor.

Authors:  Simon S Murray; Pilar Perez; Ramee Lee; Barbara L Hempstead; Moses V Chao
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

Review 8.  From Neural Crest Development to Cancer and Vice Versa: How p75NTR and (Pro)neurotrophins Could Act on Cell Migration and Invasion?

Authors:  Sabine Wislet; Geoffrey Vandervelden; Bernard Rogister
Journal:  Front Mol Neurosci       Date:  2018-08-23       Impact factor: 5.639

9.  The O-glycosylated stalk domain is required for apical sorting of neurotrophin receptors in polarized MDCK cells.

Authors:  C Yeaman; A H Le Gall; A N Baldwin; L Monlauzeur; A Le Bivic; E Rodriguez-Boulan
Journal:  J Cell Biol       Date:  1997-11-17       Impact factor: 10.539

10.  Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor.

Authors:  LiMei Wang; Jennifer J Rahn; XueQing Lun; Beichen Sun; John J P Kelly; Samuel Weiss; Stephen M Robbins; Peter A Forsyth; Donna L Senger
Journal:  PLoS Biol       Date:  2008-11-25       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.